Evidence map›Paper›PMID 36672822›Full record

ArticleGenes2022

A Rare Chromosome Rearrangement Leading to de la Chapelle Syndrome with a Mosaic 45,X Cell Line: (46,X,psu dic(X;Y)(p22.13;q11.221)/45,X/45,psu dic(X;Y)(p22.13;q11.221).

Arthur Clement, Théo Dominot, Jeremy Chammas, Martine Montagnon, Marie Delcroix, Jérôme Pfeffer, Jean Michel Dupont, Aziza Lebbar, Patrice Clement, François Vialard

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Arthur ClementClément Laboratory, F-93110 Paris, France.
Théo DominotDepartment of Cytogenetics, APHP Centre, Université de Paris, Hôpital Cochin, F-75014 Paris, France.
Jeremy ChammasZTP Laboratory, F-93170 Bobigny, France.
Martine MontagnonClément Laboratory, F-93110 Paris, France.
Marie DelcroixDepartment of Genetics, CHI de Poissy St Germain en Laye, F-78300 Poissy, France.
Jérôme PfefferZTP Laboratory, F-93170 Bobigny, France.
Jean Michel DupontDepartment of Cytogenetics, APHP Centre, Université de Paris, Hôpital Cochin, F-75014 Paris, France.
Aziza LebbarDepartment of Cytogenetics, APHP Centre, Université de Paris, Hôpital Cochin, F-75014 Paris, France.
Patrice ClementClément Laboratory, F-93110 Paris, France.
François VialardDepartment of Genetics, CHI de Poissy St Germain en Laye, F-78300 Poissy, France.ORCID 0000-0002-5774-2756
Université Paris Cité · FRCentre Hospitalier Intercommunal de Poissy · FRÉcole Nationale Vétérinaire d'Alfort · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infertility affects about 15% of couples of childbearing age. About half of these cases can be attributed predominantly to a male factor, such as a quantitative or qualitative impairment in spermatogenesis. The first-line genetic screening for non-obstructive azoospermia is limited to karyotyping (to identify chromosome abnormalities) and Y chromosome microdeletions screening, with a view to explaining the spermatogenetic failure and evaluating the likelihood of sperm retrieval in a testicular biopsy. For patients with de la Chapelle syndrome (a 46,XX karyotype with the presence of

Indexed as

SemenSex Chromosome AberrationsChromosome DeletionChromosomes, Human, YHumansInfertility, MaleMaleMosaicismSex Chromosome Disorders of Sex Development46,XX SRY-positive male syndromechromosomal rearrangementsex chromosome mosaicshort stature

Identifiers

PMID36672822
PMCPMC9858770
OpenAlexW4313413741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.